Cartesian Therapeutics, Inc. Earnings Per Share (Basic)
Cartesian Therapeutics, Inc. (RNAC) reported Earnings Per Share (Basic) of $0.47 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- Cartesian Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was $0.47, a 7.84% decline year-over-year.
- Cartesian Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$1.46.
- Cartesian Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$1.38.
- Cartesian Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-06-30 was $0.51, a 12.07% decline year-over-year.
- Cartesian Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$5.02.
- Cartesian Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$4.48.
- Cartesian Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$49.76, a 20833.33% decline from fiscal 2022.
- Cartesian Therapeutics, Inc. earnings per share, basic for fiscal 2022 was $0.24.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.47 10-Q · filed 2026-08-06 | -$0.83 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | -$1.46 10-Q · filed 2026-04-30 | |||||||
| 2025-12-31 | -$5.02 10-K · filed 2026-03-09 | |||||||
| 2025-09-30 | -$1.38 10-Q · filed 2025-11-06 | -$1.45 10-Q · filed 2025-11-06 | ||||||
| 2025-06-30 | $0.51 10-Q · filed 2026-08-06 | -$0.07 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | -$0.68 10-Q · filed 2026-04-30 | |||||||
| 2024-12-31 | -$4.48 10-K · filed 2026-03-09 | |||||||
| 2024-09-30 | -$1.13 10-Q · filed 2025-11-06 | -$4.61 10-Q · filed 2025-11-06 | ||||||
| 2024-06-30 | $0.58 10-Q · filed 2025-08-07 | -$3.88 10-Q · filed 2025-08-07 | -$28.70 derived: net income ÷ weighted average shares · filed 2025-08-07 | -$33.31 derived: net income ÷ weighted average shares · filed 2025-08-07 | ||||
| 2024-03-31 | -$10.50 10-Q · filed 2025-05-08 | -$50.81 derived: net income ÷ weighted average shares · filed 2025-05-08 | -$53.13 derived: net income ÷ weighted average shares · filed 2025-05-08 | -$55.74 derived: net income ÷ weighted average shares · filed 2025-05-08 | ||||
| 2023-12-31 | -$40.65 derived: net income ÷ weighted average shares · filed 2025-03-13 | -$42.89 derived: net income ÷ weighted average shares · filed 2025-03-13 | -$45.40 derived: net income ÷ weighted average shares · filed 2025-03-13 | -$49.76 10-K · filed 2025-03-13 | -$1.66 10-K · filed 2024-03-07 | |||
| 2023-09-30 | -$1.74 10-Q · filed 2024-11-07 | -$0.06 10-Q · filed 2023-11-13 | -$3.97 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$8.20 10-Q · filed 2024-11-07 | -$0.27 10-Q · filed 2023-11-13 | -$0.68 derived: net income ÷ weighted average shares · filed 2024-11-07 | ||
| 2023-06-30 | -$2.23 10-Q · filed 2024-08-08 | -$0.07 10-Q · filed 2023-08-17 | -$6.46 10-Q · filed 2024-08-08 | -$0.22 10-Q · filed 2023-08-17 | -$0.36 derived: net income ÷ weighted average shares · filed 2024-08-08 | -$0.35 derived: net income ÷ weighted average shares · filed 2024-08-08 | ||
| 2023-03-31 | -$4.24 10-Q · filed 2024-05-08 | -$0.14 10-Q · filed 2023-05-04 | -$0.11 derived: net income ÷ weighted average shares · filed 2024-05-08 | -$0.16 derived: net income ÷ weighted average shares · filed 2024-05-08 | -$0.07 derived: net income ÷ weighted average shares · filed 2024-05-08 | |||
| 2022-12-31 | $0.09 derived: net income ÷ weighted average shares · filed 2024-03-07 | $0.03 derived: net income ÷ weighted average shares · filed 2024-03-07 | $0.09 derived: net income ÷ weighted average shares · filed 2024-03-07 | $0.24 10-K · filed 2024-03-07 | ||||
| 2022-09-30 | -$0.05 10-Q · filed 2023-11-13 | $0.00 derived: net income ÷ weighted average shares · filed 2023-11-13 | $0.21 10-Q · filed 2023-11-13 | $0.17 derived: net income ÷ weighted average shares · filed 2024-03-07 | ||||
| 2022-06-30 | $0.06 10-Q · filed 2023-08-17 | $0.27 10-Q · filed 2023-08-17 | $0.24 derived: net income ÷ weighted average shares · filed 2024-03-07 | $0.10 derived: net income ÷ weighted average shares · filed 2024-03-07 | ||||
| 2022-03-31 | $0.23 10-Q · filed 2023-05-04 | $0.19 derived: net income ÷ weighted average shares · filed 2024-03-07 | $0.04 derived: net income ÷ weighted average shares · filed 2024-03-07 | $0.04 derived: net income ÷ weighted average shares · filed 2024-03-07 | ||||
| 2021-12-31 | $0.10 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$0.05 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$0.05 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$0.22 10-K · filed 2024-03-07 | ||||
| 2021-09-30 | -$0.16 10-Q · filed 2022-11-03 | -$0.16 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$0.34 10-Q · filed 2022-11-03 | -$0.52 derived: net income ÷ weighted average shares · filed 2023-03-02 | ||||
| 2021-06-30 | $0.04 10-Q · filed 2022-08-08 | -$0.18 10-Q · filed 2022-08-08 | -$0.36 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$0.46 derived: net income ÷ weighted average shares · filed 2023-03-02 | ||||
| 2021-03-31 | -$0.22 10-Q · filed 2022-05-05 | -$0.37 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$0.46 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$0.70 derived: net income ÷ weighted average shares · filed 2023-03-02 | ||||
| 2020-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$0.24 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$0.48 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$0.68 10-K · filed 2023-03-02 | ||||
| 2020-09-30 | -$0.09 10-Q · filed 2021-11-09 | -$0.33 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$0.54 10-Q · filed 2021-11-09 | |||||
| 2020-06-30 | -$0.25 10-Q · filed 2021-08-12 | -$0.46 10-Q · filed 2021-08-12 | ||||||
| 2019-12-31 | -$1.22 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |